Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Index
-
Market Cap
28.46M
Enterprise Value
17.59M
Income
-5.24M
Sales
69.39M
Book/sh
8.83
Cash/sh
6.15
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
157
IPO
Jan 27, 1998
P/E
-
Forward P/E
-
PEG
-
P/S
0.41
P/B
0.80
P/C
1.15
P/FCF
18.48
EV/EBITDA
-
EV/Sales
0.25
Quick Ratio
3.00
Current Ratio
3.25
Debt/Eq
0.40
LT Debt/Eq
0.29
Option/Short
No / Yes
EPS (ttm)
-1.37
EPS next Y
-0.20
EPS next Q
-0.18
EPS this Y
32.67%
EPS next Y
79.70%
EPS next 5Y
48.37%
EPS past 3/5Y
56.86% 49.20%
Sales past 3/5Y
-1.65% 2.17%
EPS Y/Y TTM
-109.07%
Sales Y/Y TTM
-21.12%
EPS Q/Q
22.91%
Sales Q/Q
10.63%
Insider Own
16.37%
Insider Trans
-0.15%
Inst Own
8.48%
Inst Trans
-1.56%
ROA
-9.32%
ROE
-15.53%
ROIC
-11.21%
Gross Margin
17.71%
Oper. Margin
-6.52%
Profit Margin
-7.55%
SMA20
-11.08%
SMA50
-11.41%
SMA200
-15.05%
Trades
Shs Outstand
3.97M
Shs Float
3.37M
52W High
12.90 -45.27%
52W Low
4.89 44.52%
Volatility
5.31% 5.35%
ATR (14)
0.43
RSI (14)
37.09
Beta
1.74
Rel Volume
0.00
Avg Volume
26.65K
Volume
0
Perf Week
-11.53%
Perf Month
-17.62%
Perf Quarter
6.49%
Perf Half Y
-17.49%
Perf YTD
-15.30%
Perf Year
-38.07%
Perf 3Y
-57.98%
Perf 5Y
-88.35%
Perf 10Y
-98.95%
Prev Close
7.06
Price
7.06
Change %
0.00%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Strobeck MarkPresident and CEOOct 01 '26Sale8.421,0008,42061,349Oct 05 04:03 PM
Strobeck MarkOfficerOct 01 '26Proposed Sale8.401,0008,400Oct 01 03:29 PM
Hunter HeatherChief Operating OfficerJan 02 '26Sale0.842,8682,396132,523Jan 05 04:15 PM
Neri JesseSVP and CFOJan 02 '26Sale0.84886740124,842Jan 05 04:13 PM
Neri JesseOfficerJan 02 '26Proposed Sale0.80886712Jan 05 09:38 AM
Hunter HeatherOfficerJan 02 '26Proposed Sale0.812,8682,318Jan 02 04:40 PM
COOPER JOHN GDirectorNov 18 '25Sale0.875,0794,419140,372Nov 18 04:26 PM
COOPER JOHN GDirectorNov 18 '25Proposed Sale0.905,0794,572Nov 18 09:54 AM
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini on October 25, 1996 and is headquartered in Wixom, MI.
PresidentDr. Mark Strobeck Ph.D.
Senior VP & CFOMr. Jesse Neri
Executive VPMs. Megan C. Timmins
Senior VP & COOMs. Heather H. Hunter
Controller & Principal Accounting OfficerMr. Nicholas Fanslau